Lanzamiento Enero 2027

Ensayo controlado aleatorizado2001Financiación no declarada

Effect of creatine supplementation on metabolism and performance in humans during intermittent sprint cycling

Finn JP, Ebert TR, Withers RT, Carey MF, Mackay M, Phillips JW, Febbraio MA

European journal of applied physiology · 19 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2001-03-12 · Eur J Appl Physiol · vol. 84 · número 3 · págs. 238–243
Editorial
Springer Science+Business Media
Citado
49 citas · más que el 75% de estudios similares · 1.2× el promedio de su campo
Referencias
0 trabajos
Acceso
De pago
Áreas de investigación
Muscle metabolism and nutrition · Sports Performance and Training · Biochemical effects in animals
Palabras clave
creatine supplementation, triathletes, phosphocreatine, citrate synthase, peak power, fatigue index, creatine loading
MeSH
muscle, skeletal, humans, lactic acid, creatinine, phosphocreatine, exercise test, body mass index, cross-over studies, double-blind method, energy metabolism, muscle fatigue, adult, physical exertion

7 autores

  • J. P. Finn
  • Tammie R. Ebert🇦🇺Flinders University
  • Robert T. Withers🇦🇺Flinders University
  • Michael Carey🇦🇺Victoria University
  • M. Mackay🇦🇺Flinders University
  • John W. Phillips🇦🇺Flinders University
  • Mark Anthony Febbraio🇦🇺The University of Melbourne

Resumen

El texto original del estudio, en el idioma en que se publicó.

This double blind study investigated the effect of oral creatine supplementation (CrS) on 4 x 20 s of maximal sprinting on an air-braked cycle ergometer. Each sprint was separated by 20 s of recovery. A group of 16 triathletes [mean age 26.6 (SD 5.1) years. mean body mass 77.0 (SD 5.8) kg, mean body fat 12.9 (SD 4.6)%, maximal oxygen uptake 4.86 (SD 0.7) l.min-1] performed an initial 4 x 20 s trial after a muscle biopsy sample had been taken at rest. The subjects were then matched on their total intramuscular creatine content (TCr) before being randomly assigned to groups to take by mouth either a creatine supplement (CRE) or a placebo (CON) before a second 4 x 20 s trial. A muscle biopsy sample was also taken immediately before this second trial. The CrS of 100 g comprised 4 x 5 g for 5 days. The initial mean TCr were 112.5 (SD 8.7) and 112.5 (SD 10.7) mmol.kg-1 dry mass for CRE and CON, respectively. After creatine loading and placebo ingestion respectively, CRE [128.7 (SD 11.8) mmol.kg-1 dry mass] had a greater (P = 0.01) TCr than CON [112.0 (SD 10.0) mmol.kg-1 dry mass]. While the increase in free creatine for CRE was statistically significant (P = 0.034), this was not so for the changes in phosphocreatine content [trial 1: 75.7 (SD 6.9), trial 2: 84.7 (SD 11.0) mmol.kg-1 dry mass, P = 0.091]. There were no significant differences between CRE and CON for citrate synthase activity (P = 0.163). There was a tendency towards improved performance in terms of 1 s peak power (in watts P = 0.07; in watts per kilogram P = 0.05), 5 s peak power (in watts P = 0.08) and fatigue index (P = 0.08) after CrS for sprint 1 of the second trial. However, there was no improvement for mean power (in watts P = 0.15; in watts per kilogram P = 0.1) in sprint 1 or for any performance values in subsequent sprints. Our results suggest that, while CrS elevates the intramuscular stores of free creatine, this does not have an ergogenic effect on 4 x 20 s all-out cycle sprints with intervening 20-s rest periods.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.